Explore News
-
Why Novo and Lilly are Racing for GLP-1 Supremacy
Novo Nordisk and Eli Lilly rivalry intensifies in GLP-1 pill market
-
New Weight Loss Drug Shows Promise
Eli Lilly’s new drug retatrutide shows significant weight loss results
-
Eli Lilly Surges into Vaccine Market with $4 Billion Acquisition
Eli Lilly expands vaccine portfolio with acquisitions
-
Eli Lilly Surges into Infectious Disease Market with $4 Billion Deals
Eli Lilly expands into infectious disease research with significant investments
-
New Weight-Loss Shot Appears to Outperform Other Obesity Drugs on Market
Eli Lilly’s new weight-loss drug helps participants lose up to 28% of body weight
-
Why Amazon’s Foundayo Delivery Matters
Amazon partners with Eli Lilly to offer Foundayo through One Medical kiosks
-
F.D.A. Approves New Eli Lilly Weight-Loss Pill, Foundayo
A new era in weight management has begun with Foundayo
